In this review, we concluded that anti-BMP6 reagents, exogenous BMP7 and FST all have impacts on decreasing IBD-associated pro-inflammatory cytokines, especially IL-6 which attenuates DSS-induced mice colitis. This evidence concerns the gene IL6 and inflammatory bowel disease.